Literature DB >> 17180346

Prevalence of fecal carriage of ESBL-producing Enterobacteriaceae in hospitalized and ambulatory patients during two non-outbreak periods.

F J Castillo García1, C Seral García, M Pardos De la Gandara, M I Millán Lou, C Pitart Ferré.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17180346     DOI： 10.1007/s10096-006-0242-8

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN： 0934-9723            Impact factor:   3.267


× No keyword cloud information.
  8 in total

1.  CTX-M-type beta-lactamases: an emerging group of extended-spectrum enzymes.

Authors:  L S Tzouvelekis; E Tzelepi; P T Tassios; N J Legakis
Journal:  Int J Antimicrob Agents       Date:  2000-03       Impact factor: 5.283

2.  Epidemiology and clinical features of infections caused by extended-spectrum beta-lactamase-producing Escherichia coli in nonhospitalized patients.

Authors:  Jesús Rodríguez-Baño; Maria Dolores Navarro; Luisa Romero; Luis Martínez-Martínez; Miguel A Muniain; Evelio J Perea; Ramón Pérez-Cano; Alvaro Pascual
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948

3.  Dramatic increase in prevalence of fecal carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceae during nonoutbreak situations in Spain.

Authors:  Aránzazu Valverde; Teresa M Coque; M Paz Sánchez-Moreno; Azucena Rollán; Fernando Baquero; Rafael Cantón
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

4.  [Broad-spectrum beta-lactamases in enterobacteria from hospitalized and ambulatory patients in Zaragoza (Spain), 2001-2004].

Authors:  Francisco Javier Castillo-García; Cristina Seral-García; Isabel Millán-Lou; María Pardos-De la Gandara
Journal:  Enferm Infecc Microbiol Clin       Date:  2006-11       Impact factor: 1.731

5.  Detection of extended broad-spectrum beta-lactamases in Enterobacteriaceae in four French hospitals.

Authors:  P Legrand; G Fournier; A Buré; V Jarlier; M H Nicolas; D Decré; J Duval; A Philippon
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-06       Impact factor: 3.267

6.  Epidemiology and successful control of a large outbreak due to Klebsiella pneumoniae producing extended-spectrum beta-lactamases.

Authors:  C Peña; M Pujol; C Ardanuy; A Ricart; R Pallares; J Liñares; J Ariza; F Gudiol
Journal:  Antimicrob Agents Chemother       Date:  1998-01       Impact factor: 5.191

7.  Prospective survey of colonization and infection caused by expanded-spectrum-beta-lactamase-producing members of the family Enterobacteriaceae in an intensive care unit.

Authors:  C De Champs; M P Sauvant; C Chanal; D Sirot; N Gazuy; R Malhuret; J C Baguet; J Sirot
Journal:  J Clin Microbiol       Date:  1989-12       Impact factor: 5.948

8.  Community transmission of extended-spectrum beta-lactamase.

Authors:  Beatriz Mirelis; Ferran Navarro; Elisenda Miró; Raul Jesús Mesa; Pere Coll; Guillem Prats
Journal:  Emerg Infect Dis       Date:  2003-08       Impact factor: 6.883
  8 in total
  6 in total

1.  Risk factors for, and clinical relevance of, faecal extended-spectrum β-lactamase producing Escherichia coli (ESBL-EC) carriage in neutropenic patients with haematological malignancies.

Authors:  M Arnan; C Gudiol; L Calatayud; J Liñares; M Á Dominguez; M Batlle; J M Ribera; J Carratalà; F Gudiol
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-10-30       Impact factor: 3.267

Review 2.  Trends in human fecal carriage of extended-spectrum β-lactamases in the community: toward the globalization of CTX-M.

Authors:  Paul-Louis Woerther; Charles Burdet; Elisabeth Chachaty; Antoine Andremont
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

3.  High prevalence of fecal carriage of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a pediatric unit in Madagascar.

Authors:  Todisoa Andriatahina; Frédérique Randrianirina; Eliosa Ratsima Hariniana; Antoine Talarmin; Honoré Raobijaona; Yves Buisson; Vincent Richard
Journal:  BMC Infect Dis       Date:  2010-07-12       Impact factor: 3.090

4.  Rectal carriage of extended-spectrum beta-lactamase-producing gram-negative bacilli in community settings in Madagascar.

Authors:  Perlinot Herindrainy; Frédérique Randrianirina; Rila Ratovoson; Elisoa Ratsima Hariniana; Yves Buisson; Nathalie Genel; Dominique Decré; Guillaume Arlet; Antoine Talarmin; Vincent Richard
Journal:  PLoS One       Date:  2011-07-29       Impact factor: 3.240

5.  Local prevalence of extended-spectrum beta-lactamase (ESBL) producing Enterobacteriaceae intestinal carriers at admission and co-expression of ESBL and OXA-48 carbapenemase in Klebsiella pneumoniae: a prevalence survey in a Spanish University Hospital.

Authors:  Cristina Díaz-Agero Pérez; Nieves López-Fresneña; Angela L Rincon Carlavilla; Marta Hernandez Garcia; Patricia Ruiz-Garbajosa; Jesús María Aranaz-Andrés; Friederike Maechler; Petra Gastmeier; Marc J M Bonten; Rafael Canton
Journal:  BMJ Open       Date:  2019-03-01       Impact factor: 2.692

6.  Faecal carriage of extended-spectrum β-lactamase (ESBL)-producing enterobacteria in liver disease patients from two hospitals in Egypt and France: a comparative epidemiological study.

Authors:  N S Fam; S Defasque; F Bert; V Leflon-Guibout; A El-Ray; M El-Ghannam; M E Attia; M Omar; D G Desouki; D Valla; M-H Nicolas-Chanoine
Journal:  Epidemiol Infect       Date:  2014-07-18       Impact factor: 4.434
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.